Feasibility of the Multiple Sclerosis Performance Test in Participants With Multiple Sclerosis

TerminatedOBSERVATIONAL
Enrollment

3,073

Participants

Timeline

Start Date

June 17, 2019

Primary Completion Date

December 5, 2022

Study Completion Date

December 5, 2022

Conditions
Multiple Sclerosis
Interventions
OTHER

Multiple Sclerosis Performance Test (MSPT)

Administered as specified in the treatment arm.

Trial Locations (33)

3010

Research Site, Bern

4031

Research Site, Basel

10043

Research Site, Orbassano

12000

Research Site, Prague

14202

Research Site, Buffalo

15212

Research Site, Pittsburgh

19104

Research Site, Philadelphia

20007

Research Site, Washington D.C.

20132

Research Site, Milan

27710

Research Site, Durham

30309

Research Site, Atlanta

30327

Research Site, Atlanta

48334

Research Site, Farmington Hills

48867

Research Site, Owosso

60008

Research Site, Chicago

63131

Research Site, St Louis

67200

Research Site, Strasbourg

70124

Research Site, Bari

73104

Research Site, Oklahoma City

80045

Research Site, Aurora

84103

Research Site, Salt Lake City

94705

Research Site, Berkeley

95123

Research Site, Catania

97225

Research Site, Portland

98122

Research Site, Seattle

99208

Research Site, Spokane

90033-5310

Research Site, Los Angeles

02215

Research Site, Boston

07666

Research Site, Teaneck

75390-8806

Research Site, Dallas

00185

Research Site, Roma

GU16 7UJ

Research Site, Camberley

OX3 9DU

Research Site, Oxford

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biogen

INDUSTRY